Skip to content

CVCT CardioBrief

  • Home
  • About
    • Mission
  • CVCT Forum
  • Cardiobrief Archive
  • FAQ
    • Contact
    • Privacy Policy
    • Cookies Policy
    • Terms of use
  • Contact
  • Privacy Policy
  • Cookies Policy
  • Terms of use
search
  • Contact
  • Privacy Policy
  • Cookies Policy
  • Terms of use
search

Login / Signup

August 09, 20182018-08-09T22:40:19-04:00

Lancet Paper Adds To Evidence That Reducing Salt To Very Low Levels May Be Dangerous

By : Larry Husten

A new paper from a very large ongoing observational study offers additional and more powerful evidence that dramatic reductions in salt consumption may not be…

July 26, 2018

No, A Big NIH Trial Did Not Show That Lowering Blood Pressure Will Prevent Dementia

By : Larry Husten

It’s “breakthrough” time again. News reports out of the Alzheimer’s Association International Conference (AAIC) this week have been relentlessly upbeat and positive about findings from the…

July 10, 20182018-07-09T23:37:25-04:00

If You Look For Atrial Fibrillation You Will Find Atrial Fibrillation

By : Larry Husten

If you look hard to find people who have atrial fibrillation (AF) you will in fact find people who have atrial fibrillation, a new paper published…

May 21, 2018

Salt War Opponents Unite In Call For Randomized Trial In Prisons

By : Larry Husten

The opposing camps in the salt wars don’t agree on much, but they have now found common ground in their belief that the only way…

March 30, 20182018-03-30T13:23:18-04:00

More Controversy Over Major Cardiology Clinical Trial

By : Larry Husten

Think about this: A new article reports that a major NIH-funded trial runs into trouble. The article raises all sorts of fundamental questions about our…

March 18, 20182018-03-30T13:22:10-04:00

Cardiology World Erupts Into Controversy Over Change In Major Clinical Trial

By : Larry Husten

As a major clinical trial in cardiology nears completion it has provoked a storm of criticism and controversy. The brouhaha erupted in response to a…

March 10, 20182018-03-10T09:09:54-05:00

The ODYSSEY Trial Ends Well— But Will It Be Enough?

By : Larry Husten

Sanofi and Regeneron achieved a modest victory with the much anticipated ODYSSEY Outcomes trial of its cholesterol lowering drug Praluent (alirocumab). The trial met its…

March 07, 20182018-03-06T22:14:42-05:00

Esperion Releases Top Line Results For First Pivotal Phase 3 Study

By : Larry Husten

Esperion announced positive results today for the first in a series of pivotal phase 3 studies of its cholesterol lowering drug. The trial (Study 4,…

February 20, 20182018-02-20T13:25:37-05:00

Low-Carb And Low-Fat Diets Battle To A Draw

By : Larry Husten

A new study comparing a low-carbohydrate diet with a low-fat diet found no important differences in weight loss or other important outcomes between the two…

Moment Of Truth For Struggling And Expensive Cholesterol Drugs
February 15, 2018

Moment Of Truth For Struggling And Expensive Cholesterol Drugs

By : Larry Husten

It will be the moment of truth for the expensive new cholesterol drugs known as PCSK9 inhibitors. Next month we will learn much more about…

Posts navigation

1 2 … 64 Next

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 296 other subscribers

  • Contact
  • Privacy Policy
  • Cookies Policy
  • Terms of use
  • Contact
  • Privacy Policy
  • Cookies Policy
  • Terms of use
 

Loading Comments...
 

You must be logged in to post a comment.